0001493152-24-007491.txt : 20240221 0001493152-24-007491.hdr.sgml : 20240221 20240221214631 ACCESSION NUMBER: 0001493152-24-007491 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240216 FILED AS OF DATE: 20240221 DATE AS OF CHANGE: 20240221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hariri Robert J CENTRAL INDEX KEY: 0001398815 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38914 FILM NUMBER: 24662093 MAIL ADDRESS: STREET 1: 341 MENDHAM ROAD CITY: BERNARDSVILLE STATE: NJ ZIP: 07924 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celularity Inc CENTRAL INDEX KEY: 0001752828 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 831702591 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 170 PARK AVE CITY: FLORHAM PARK STATE: NJ ZIP: 07932 BUSINESS PHONE: (908) 768-2170 MAIL ADDRESS: STREET 1: 170 PARK AVE CITY: FLORHAM PARK STATE: NJ ZIP: 07932 FORMER COMPANY: FORMER CONFORMED NAME: GX Acquisition Corp. DATE OF NAME CHANGE: 20180912 4 1 ownership.xml X0508 4 2024-02-16 0 0001752828 Celularity Inc CELU 0001398815 Hariri Robert J C/O CELULARITY INC. 170 PARK AVENUE FLORHAM PARK NJ 07932 1 1 0 0 Chief Executive Officer 0 Stock Option Grant (Right to Buy) 0.4340 2024-02-16 4 A 0 2937788 0.00 A 2034-02-15 Class A Common Stock 2937788 2937788 D The option was granted pursuant to the Issuer's 2021 Equity Incentive Plan. The shares underlying such option will vest in equal quarterly installments during 2024 such that 25% of the option will vest on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024, subject to the Reporting Person's continuous service with the Issuer through each such date. /s/ Kyle Fletcher, Attorney-in-Fact 2024-02-21